TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia · Delayed Price · Currency is MYR 0.4450
+0.0050 (1.14%)
At close: Aug 28, 2026
TMC Life Sciences Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 17.38 | 3.61 | 40.65 | 39.26 | 41.39 |
Depreciation & Amortization | 30.86 | 28.25 | 25.16 | 23.54 | 14.64 |
Other Amortization | 6.47 | 5.85 | 2.75 | 2.47 | 1.21 |
Loss (Gain) From Sale of Assets | -0 | -0.01 | - | 0.01 | 0 |
Asset Writedown & Restructuring Costs | 0.05 | 0.04 | 0.07 | 0.01 | 0.06 |
Stock-Based Compensation | - | 0.02 | 0.06 | 0.13 | 0.24 |
Provision & Write-off of Bad Debts | 0.66 | 0.65 | 0.15 | 1.75 | -0.05 |
Other Operating Activities | 15.96 | -2.62 | 5.7 | -1.69 | -19.86 |
Change in Accounts Receivable | -3.66 | -14.65 | 8.75 | - | -14.61 |
Change in Inventory | -4.77 | -4.43 | 1.62 | - | -0.79 |
Change in Accounts Payable | -5.35 | 5.72 | -10.91 | 13.34 | 13.41 |
Change in Unearned Revenue | 0.1 | 0.09 | 0.78 | - | - |
Change in Other Net Operating Assets | - | - | - | -24.24 | - |
Operating Cash Flow | 57.69 | 22.51 | 74.76 | 54.57 | 35.65 |
Operating Cash Flow Growth | 156.32% | -69.90% | 37.00% | 53.09% | 58.79% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -13.73 | -40.71 | -25.35 | -31.96 | -67.69 |
Sale of Property, Plant & Equipment | 0.02 | 0.01 | - | 0 | - |
Sale (Purchase) of Intangibles | -1.02 | -0.43 | -3.2 | -2.5 | -1 |
Other Investing Activities | 33.06 | 36.49 | -25.63 | -4.47 | -5.67 |
Investing Cash Flow | 18.33 | -4.64 | -54.17 | -38.92 | -74.36 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | - | - | 2.98 | 17.25 | 38.94 |
Total Debt Issued | - | - | 2.98 | 17.25 | 38.94 |
Long-Term Debt Repaid | -40.51 | -25.94 | -18.01 | -10.39 | -2.82 |
Total Debt Repaid | -40.51 | -25.94 | -18.01 | -10.39 | -2.82 |
Net Debt Issued (Repaid) | -40.51 | -25.94 | -15.03 | 6.86 | 36.13 |
Common Dividends Paid | -3.25 | -38.62 | -14.63 | -4.81 | -3.86 |
Financing Cash Flow | -43.75 | -64.55 | -29.66 | 2.04 | 32.27 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | 32.27 | -46.69 | -9.07 | 17.69 | -6.44 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 43.96 | -18.2 | 49.41 | 22.61 | -32.04 |
Free Cash Flow Growth | - | - | 118.56% | - | - |
Free Cash Flow Margin | 11.19% | -5.27% | 14.26% | 7.26% | -13.15% |
Free Cash Flow Per Share | 0.03 | -0.01 | 0.03 | 0.01 | -0.02 |
Levered Free Cash Flow | 44.97 | -27.6 | 32.98 | -5.86 | -43.5 |
Unlevered Free Cash Flow | 49.65 | -21.77 | 39.38 | 0.01 | -42.19 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 7.27 | 9.13 | 10.18 | 9.34 | 6.43 |
Cash Income Tax Paid | -10.14 | 2.27 | 0.98 | 0.8 | 4.34 |
Change in Working Capital | -13.69 | -13.27 | 0.24 | -10.9 | -1.98 |